title: Apatite content of collagen materials dose-dependently increases pre-osteoblastic cell deposition of a cement line-like matrix.
authors.affiliation: Université de Lyon, F42023, Saint-Etienne, France.
authors.forename: A
authors.initials: A
authors.lastname: Perrier
authors.forename: V
authors.initials: V
authors.lastname: Dumas
authors.forename: M T
authors.initials: MT
authors.lastname: Linossier
authors.forename: C
authors.initials: C
authors.lastname: Fournier
authors.forename: P
authors.initials: P
authors.lastname: Jurdic
authors.forename: A
authors.initials: A
authors.lastname: Rattner
authors.forename: L
authors.initials: L
authors.lastname: Vico
authors.forename: A
authors.initials: A
authors.lastname: Guignandon
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001031:Apatites / Q000494:pharmacology*; D001672:Biocompatible Materials / Q000494:pharmacology*; D001696:Biomechanical Phenomena / Q000187:drug effects; D001843:Bone Cements / Q000494:pharmacology*; D001857:Bone Matrix / Q000187:drug effects / Q000378:metabolism*; D002113:Calcification, Physiologic / Q000187:drug effects; D002448:Cell Adhesion / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D003094:Collagen / Q000494:pharmacology*; D005353:Fibronectins / Q000378:metabolism; D051379:Mice; D009842:Oligopeptides / Q000494:pharmacology; D010006:Osteoblasts / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D010641:Phenotype; D012995:Solubility / Q000187:drug effects; D013379:Substrate Specificity / Q000187:drug effects
chemical_list: D001031:Apatites; D001672:Biocompatible Materials; D001843:Bone Cements; D005353:Fibronectins; D009842:Oligopeptides; C047981:arginyl-glycyl-aspartic acid; D003094:Collagen